Dextrose Monohydrate 5% Inje · 1,666 days since initial FDA posting
Brand: DEXTROSE
FDA lists Dextrose Monohydrate 5% Inje as Active Shortage (Otsuka ICU Medical LLC).
Availability on file: Available
Dextrose Monohydrate 5% Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Dextrose Monohydrate 5% Injection
- Manufacturer
- Otsuka ICU Medical LLC
- Dosage Form
- Injection
- Presentation
- Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-03)
- Package NDC
- 0990-7922-03
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Feb 14, 2022
- Last Updated
- Mar 18, 2026
- Therapeutic Category
- Endocrinology/Metabolism, Gastroenterology, Other, Pediatric
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
Nearby, Other Dextrose Shortage Records
Dextrose Monohydrate 10% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 5% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 5% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 10% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 5% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 10% Injection
B. Braun Medical Inc.
Injection
FDA reason on file: This product is distributed by ICU Medical. General shortage guidance lives on the tracker hub.